Cargando…

A DESCRIPTIVE, RETROSPECTIVE ANALYSIS OF COVID-19 ANTIBODY THERAPY AND ITS EFFECTS ON MORBIDITY AND MORTALITY IN PATIENTS RECEIVING B-LYMPHOCYTE DEPLETING THERAPIES

INTRO: Patients receiving B-cell depleting or inhibiting therapies (BCDT), such as anti-CD20 monoclonal antibodies (CD20-MAB), are at risk for severe COVID-19. BCDT decreases production of neutralizing antibodies, causing delayed viral clearance and prolonged viral shedding. Passive antibody therapy...

Descripción completa

Detalles Bibliográficos
Autores principales:	Simeunovic, G., Sullivan, L., Gentile, S., Brooks, H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Published by Elsevier Ltd. 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10186901/ http://dx.doi.org/10.1016/j.ijid.2023.04.286

Ejemplares similares

527. A Descriptive, Retrospective Analysis of COVID-19 Antibody Therapy and its Effects on Morbidity and Mortality in Patients Receiving B-cell Depleting Therapies
por: SIMEUNOVIC, G O R D A N A, et al.
Publicado: (2023)

Antibody-mediated cell depletion therapies in multiple sclerosis
por: Mariottini, Alice, et al.
Publicado: (2022)

Platelet-to-Lymphocyte Ratio and In-Hospital Mortality in Patients With AKI Receiving Continuous Kidney Replacement Therapy: A Retrospective Observational Cohort Study
por: Jeon, You Hyun, et al.
Publicado: (2023)

Towards an ontological representation of morbidity and mortality in Description Logics
por: Santana, Filipe, et al.
Publicado: (2012)

B cell depletion therapies in autoimmune diseases: Monoclonal antibodies or chimeric antigen receptor-based therapy?
por: Zhang, Zheng, et al.
Publicado: (2023)

Descriptive epidemiology of morbidity and mortality in Minnesota dairy heifer calves
por: Sivula, N.J, et al.
Publicado: (1996)

1148. Relationship Between the Duration of Symptoms Before and COVID-19 Disease Outcome After Monoclonal Antibody Therapy
por: Hubbard, Michael J, et al.
Publicado: (2022)

Lymphocyte Depletion Rate as a Biomarker of Radiation Dose to Circulating Lymphocytes During Fractionated Partial-Body Radiation Therapy
por: Ellsworth, Susannah G., et al.
Publicado: (2022)

THE ANTIBODY RESPONSE OF RATS DEPLETED OF LYMPHOCYTES BY CHRONIC DRAINAGE FROM THE THORACIC DUCT
por: McGregor, D. D., et al.
Publicado: (1963)

Strong T-cell activation in response to COVID-19 vaccination in multiple sclerosis patients receiving B-cell depleting therapies
por: Alfonso-Dunn, Roberto, et al.
Publicado: (2022)

Retrospective Analysis of Vaccinated and Unvaccinated COVID-19 Patients Treated with Monoclonal Antibodies (mAb) and Their Emergent Needs (RAVEN)
por: Simeunovic, Gordana, et al.
Publicado: (2023)

Influenza Morbidity and Mortality in Elderly Patients Receiving Statins: A Cohort Study
por: Kwong, Jeffrey C., et al.
Publicado: (2009)

Antibody distribution and dosimetry in patients receiving radiolabelled antibody therapy for colorectal cancer.
por: Begent, R. H., et al.
Publicado: (1989)

A retrospective descriptive investigation of adult patients receiving third-line antiretroviral therapy in the North West province, South Africa
por: Rudman, Christian, et al.
Publicado: (2020)

Enhancement of electroporation facilitated immunogene therapy via T-reg depletion
por: Forde, P F, et al.
Publicado: (2014)

Assessment of prognostic value of preoperative neutrophil-to-lymphocyte ratio for postoperative mortality and morbidity
por: Zhu, Yingchao, et al.
Publicado: (2023)

Therapy-related Myeloid Neoplasms in Patients With Chronic Lymphocytic Leukemia Who Received FCR/FC as Frontline Therapy
por: Laribi, Kamel, et al.
Publicado: (2022)

Evaluation of Antibody and T Cell Responses to COVID-19 Vaccination in Patients with Lymphoid Malignancies Receiving B Cell-Depleting Agents
por: Goel, Shipra, et al.
Publicado: (2022)

Early Experience With Neutralizing Monoclonal Antibody Therapy for COVID-19: Retrospective Cohort Survival Analysis and Descriptive Study
por: Jarrett, Mark, et al.
Publicado: (2021)

Treating Patients With ANCA-Associated Vasculitis and Very Severe Renal Injury With an Intensified B Cell Depletion Therapy: Comparison With a Control Cohort Receiving a Conventional Therapy
por: Roccatello, Dario, et al.
Publicado: (2022)

Antibody isotype-specific engagement of Fcγ receptors regulates B lymphocyte depletion during CD20 immunotherapy
por: Hamaguchi, Yasuhito, et al.
Publicado: (2006)

501. Risk Factors for Persistent Active COVID-19 Among Patients Receiving B-Cell Depleting Therapy versus Non-B-Cell Immunosuppression
por: Voll, Kevin, et al.
Publicado: (2023)

The quest for personalized B-cell depletion therapy in rheumatic disease
por: Nistala, Kiran, et al.
Publicado: (2014)

The effects of COVID-19 infection on the mortality of patients receiving rituximab therapy
por: Ekin, Ali, et al.
Publicado: (2022)

Description of Major Osteoporotic Fractures in Women with Invasive Breast Cancer Who Received Endocrine Therapy
por: Lo, Joan C., et al.
Publicado: (2021)

Neutralising antibodies in patients with multiple myeloma receiving maintenance therapy with interferon alpha 2b.
por: Bell, J. B., et al.
Publicado: (1994)

Hyperglycemia in Hospitalized Patients Receiving Parental Nutrition Is Associated with Increased Morbidity and Mortality: A Review
por: Kumar, Puja Rajender, et al.
Publicado: (2011)

Lymphocyte Depletion in Experimental Hemorrhagic Shock in Swine
por: Hawksworth, Jason S, et al.
Publicado: (2012)

Telemedicine and its impact on heart failure morbidity and mortality
por: Tan, M.M., et al.
Publicado: (2022)

Growth differentiation factor-15 predicts mortality and morbidity after cardiac resynchronization therapy
por: Foley, Paul W.X., et al.
Publicado: (2009)

AB125. Androgen deprivation therapy for prostate cancer is associated with cardiovascular morbidity and mortality
por: Niu, Yuanjie, et al.
Publicado: (2015)

AB187. Androgen deprivation therapy for prostate cancer is associated with cardiovascular morbidity and mortality
por: Niu, Yuanjie, et al.
Publicado: (2016)

SAT-284 Sex Hormone Replacement Therapy in Turner Syndrome and the Impact on Morbidity and Mortality
por: Viuff, Mette, et al.
Publicado: (2019)

Cardiovascular diseases morbidity and mortality among children, adolescents and young adults with dialysis therapy
por: Li, Lung-Chih, et al.
Publicado: (2023)

Feasibility of Using Bacteriophage Therapy to Reduce Morbidity and Mortality Associated with Spinal Epidural Abscesses
por: Doub, James B., et al.
Publicado: (2023)

Immune reconstitution 20 years after treatment with alemtuzumab in a rheumatoid arthritis cohort: implications for lymphocyte depleting therapies
por: Cooles, Faye A. H., et al.
Publicado: (2016)

Neutrophil lymphocyte ratio and duration of prior anti-angiogenic therapy as biomarkers in metastatic RCC receiving immune checkpoint inhibitor therapy
por: Jeyakumar, Ghayathri, et al.
Publicado: (2017)

Carnitine deficiency among hospitalized pediatric patients: A retrospective study of critically ill patients receiving extracorporeal membrane oxygenation therapy
por: Kelley, Jenna, et al.
Publicado: (2021)

493. Incidence and Characterization of Chronic Active COVID Among Patients Infected with the Novel Coronavirus (COVID-19) Receiving B-cell Depleting Therapies (BCDTs)
por: Kartes, Jacob, et al.
Publicado: (2021)

Antibody and T cell responses to COVID-19 vaccination in patients receiving anticancer therapies
por: Rouhani, Sherin Juliet, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_e34hnisighnhapfjs7hm28lgdq